title: Midazolam and amplitude-integrated EEG.
abstract: Amplitude-integrated EEG (aEEG) is currently used in an increasing number of neonatal intensive care units. The method has been practised in newborn infants for more than 20 y. However, it was not until recently, when the method proved to be accurate for very early prediction of outcome in asphyxiated newborn infants, that it gained more widespread neonatal use. The use of aEEG in units for neonatal intensive care has increased the awareness that sick infants develop subclinical seizure activity, and that several medications affect the aEEG background.
authors.affiliation: Department of Paediatrics, University Hospital, Lund, Sweden. lena.westas@vgregion.se
authors.forename: L
authors.initials: L
authors.lastname: Hellström-Westas
mesh_terms: D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001238:Asphyxia Neonatorum / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D004569:Electroencephalography / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D008874:Midazolam / Q000494:pharmacology* / Q000627:therapeutic use; D012640:Seizures / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control
chemical_list: D000927:Anticonvulsants; D008874:Midazolam